Article Details

De-risking drug development through precision neuroscience - Nature

Retrieved on: 2024-09-02 13:24:43

Tags for this article:

Click the tags to see associated articles and topics

De-risking drug development through precision neuroscience - Nature. View article details on hiswai:

Excerpt

Engrail has since attracted significant investment from high-quality investors such as F-Prime Capital, Forbion, and Norwest Venture Partners in ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up